Both in Pharmaceuticals
Apnimed vs Immix Biopharma
Over the past year APMD returned −28.3% and IMMX returned −32.8%; their daily moves had a correlation of 0.34.
APMD −28.3% IMMX −32.8%Growth of $1, one year, split-adjusted
| Metric | APMD | IMMX |
|---|---|---|
| Price | $18.81 | $8.16 |
| Market cap | $783.1M | $676.5M |
| Today | +1.51% | −2.28% |
| 1 month | −13.0% | −30.3% |
| 6 months | — | −17.2% |
| Year to date | — | +56.0% |
| 1 year | — | +164.1% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | — | $232.1M |
| Dividend yield | — | — |
| Volatility (60d) | — | 72.3% |
| Short % of float | 9.8% | 21.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).